PENTIXAPHARM
PentixaPharm GmbH, a joint venture of Scintomics GmbH and 1717 Life Science Ventures GmbH, is committed to develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair, specifically targeting the CXCR4-receptor expressed in most fast progressing diseases, particularly malignant cancers. Funding is dedicated for a phase II trial of the imaging compound PentixaFor and for a phase I trial of the therapeutic compound PentixaTher in Central Nervous System (CNS) Lymphoma while supporting proof-of-concept studies in various other indications.
PENTIXAPHARM
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Würzburg, Bayern, Germany
Country:
Germany
Website Url:
http://www.pentixapharm.com
Total Employee:
1+
Status:
Active
Total Funding:
15 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network JsDelivr Dynatrace
Similar Organizations
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Current Employees Featured
Hakim Bouterfa Co-Chief Executive Officer, Founder and Managing Director @ Pentixapharm
Co-Chief Executive Officer, Founder and Managing Director
2010-01-01
Founder
Investors List
Eckert Life Science Accelerator
Eckert Life Science Accelerator investment in Series A - Pentixapharm
Official Site Inspections
http://www.pentixapharm.com Semrush global rank: 5.2 M Semrush visits lastest month: 1.56 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
